{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:36:29Z","timestamp":1786703789877,"version":"build-2736575974"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"crossref","award":["ICMR\/26\/4753\/SGP-2024"],"award-info":[{"award-number":["ICMR\/26\/4753\/SGP-2024"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12573-5","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:11:46Z","timestamp":1786702306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNAs in dilated cardiomyopathy: from biomarkers to therapeutic targets"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0019-6168","authenticated-orcid":false,"given":"Abisha Vince Jeo","family":"V S","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3821-1492","authenticated-orcid":false,"given":"P. S. Sneha","family":"Sandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8933-6747","authenticated-orcid":false,"given":"Mahesh Mundalil","family":"Vasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4172-4307","authenticated-orcid":false,"given":"Jeemon","family":"Panniyammakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9356-6796","authenticated-orcid":false,"given":"Sanjay","family":"Ganapathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1536-3686","authenticated-orcid":false,"given":"Madhusoodanan","family":"Urulangodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4595-2331","authenticated-orcid":false,"given":"Neethu","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1610-7323","authenticated-orcid":false,"given":"P. R. Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3102-3603","authenticated-orcid":false,"given":"Srikant","family":"Ambatipudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2389-708X","authenticated-orcid":false,"given":"Jyothi","family":"Vijay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8754-4243","authenticated-orcid":false,"given":"Sivadasanpillai","family":"Harikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"1","key":"12573_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","volume":"5","author":"HP Schultheiss","year":"2019","unstructured":"Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE, Liu PP, Matsumori A, Mazzanti A, McMurray J, Priori SG (2019) Dilated cardiomyopathy. Nat Reviews Disease Primers 5(1):32. https:\/\/doi.org\/10.1038\/s41572-019-0084-1","journal-title":"Nat Reviews Disease Primers"},{"key":"12573_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41569-024-01074-2","volume":"22","author":"M Gigli","year":"2025","unstructured":"Gigli M, Stolfo D, Merlo M, Sinagra G, Taylor MRG, Mestroni L (2025) Pathophysiology of dilated cardiomyopathy: From mechanisms to precision medicine. Nat Reviews Cardiol 22:183\u2013198. https:\/\/doi.org\/10.1038\/s41569-024-01074-2","journal-title":"Nat Reviews Cardiol"},{"key":"12573_CR3","doi-asserted-by":"publisher","first-page":"129714","DOI":"10.1016\/j.ijbiomac.2024.129714","volume":"261","author":"MM Vasu","year":"2024","unstructured":"Vasu MM, Koshy L, Ganapathi S, Jeemon P, Urulangodi M, Gopala S, Greeva P, Anitha A, Reethu S, Divya P, Shamla S, Sumitha K, Madhavan M, Vineeth CP, Kochumoni R, Harikrishnan S (2024) Identification of novel endogenous control miRNAs in heart failure for normalization of qPCR data. Int J Biol Macromol 261:129714. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129714","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"12573_CR4","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/biomedicines12081643","volume":"12","author":"DA Arnautu","year":"2024","unstructured":"Arnautu DA, Cozma D, Lala IR, Arnautu SF, Tomescu MC, Andor M (2024) Risk Assessment and Personalized Treatment Options in Inherited Dilated Cardiomyopathies: A Narrative Review. Biomedicines 12(8):1643. https:\/\/doi.org\/10.3390\/biomedicines12081643","journal-title":"Biomedicines"},{"issue":"10092","key":"12573_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","volume":"390","author":"RG Weintraub","year":"2017","unstructured":"Weintraub RG, Semsarian C, Macdonald P (2017) Dilated cardiomyopathy. Lancet 390(10092):400\u2013414. https:\/\/doi.org\/10.1016\/S0140-6736(16)31713-5","journal-title":"Lancet"},{"issue":"4","key":"12573_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/joim.12944","volume":"286","author":"D Reichart","year":"2019","unstructured":"Reichart D, Magnussen C, Zeller T, Blankenberg S (2019) Dilated cardiomyopathy: From epidemiologic to genetic phenotypes\u2014A translational review of current literature. J Intern Med 286(4):362\u2013375. https:\/\/doi.org\/10.1111\/joim.12944","journal-title":"J Intern Med"},{"key":"12573_CR7","doi-asserted-by":"publisher","unstructured":"Naso P, Falco L, Porcari A et al (2019) Epidemiology. In G. Sinagra, M. Merlo, & B. Pinamonti (Eds.), Dilated cardiomyopathy: From genetics to clinical management (Chap. 2). Springer. https:\/\/doi.org\/10.1007\/978-3-030-13864-6_2","DOI":"10.1007\/978-3-030-13864-6_2"},{"issue":"7","key":"12573_CR8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","volume":"121","author":"EM McNally","year":"2017","unstructured":"McNally EM, Mestroni L (2017) Dilated cardiomyopathy: Genetic determinants and mechanisms. Circul Res 121(7):731\u2013748. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309396","journal-title":"Circul Res"},{"issue":"9","key":"12573_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger RE, Hedges DJ, Morales A (2013) Dilated cardiomyopathy: The complexity of a diverse genetic architecture. Nat Reviews Cardiol 10(9):531\u2013547. https:\/\/doi.org\/10.1038\/nrcardio.2013.105","journal-title":"Nat Reviews Cardiol"},{"issue":"23","key":"12573_CR10","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS et al (2016) Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association. Circulation 134(23):e579\u2013e646. https:\/\/doi.org\/10.1161\/CIR.0000000000000455","journal-title":"Circulation"},{"key":"12573_CR11","doi-asserted-by":"publisher","first-page":"e06","DOI":"10.15420\/cfr.2023.24","volume":"10","author":"MA Alzaabi","year":"2024","unstructured":"Alzaabi MA, Abdelsalam A, Alhammadi M, Hani HB, Almheiri A, Al Matrooshi N, Zaman A, K (2024) Evaluating biomarkers as tools for early detection and prognosis of heart failure: A comprehensive review. Cardiac Fail Rev 10:e06. https:\/\/doi.org\/10.15420\/cfr.2023.24","journal-title":"Cardiac Fail Rev"},{"key":"12573_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/etm.2023.12024","volume":"26","author":"L Zhou","year":"2023","unstructured":"Zhou L, Peng F, Li J, Gong H (2023) Exploring novel biomarkers in dilated cardiomyopathy-induced heart failure by integrated analysis and in vitro experiments. Experimental Therapeutic Med 26:325. https:\/\/doi.org\/10.3892\/etm.2023.12024","journal-title":"Experimental Therapeutic Med"},{"issue":"9","key":"12573_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/jclinpath-2019-206404","volume":"73","author":"G Mansueto","year":"2020","unstructured":"Mansueto G, Benincasa G, Della Mura N, Nicoletti GF, Napoli C (2020) Epigenetic-sensitive liquid biomarkers and personalized therapy in advanced heart failure: A focus on cell-free DNA and microRNAs. J Clin Pathol 73(9):535\u2013543. https:\/\/doi.org\/10.1136\/jclinpath-2019-206404","journal-title":"J Clin Pathol"},{"issue":"5","key":"12573_CR14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843\u2013854. https:\/\/doi.org\/10.1016\/0092-8674(93)90529-y","journal-title":"Cell"},{"issue":"6808","key":"12573_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35040556","volume":"408","author":"AE Pasquinelli","year":"2000","unstructured":"Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, M\u00fcller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408(6808):86\u201389. https:\/\/doi.org\/10.1038\/35040556","journal-title":"Nature"},{"issue":"2","key":"12573_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 9(2):102\u2013114. https:\/\/doi.org\/10.1038\/nrg2290","journal-title":"Nat Rev Genet"},{"key":"12573_CR17","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.2741\/2865","volume":"13","author":"MP Perron","year":"2008","unstructured":"Perron MP, Provost P (2008) Protein interactions and complexes in human microRNA biogenesis and function. Front Biosci 13:2537\u20132547. https:\/\/doi.org\/10.2741\/2865","journal-title":"Front Biosci"},{"key":"12573_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 9:402. https:\/\/doi.org\/10.3389\/fendo.2018.00402","journal-title":"Front Endocrinol"},{"issue":"7330","key":"12573_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature09783","volume":"469","author":"EM Small","year":"2011","unstructured":"Small EM, Olson EN (2011) Pervasive roles of microRNAs in cardiovascular biology. Nature 469(7330):336\u2013342. https:\/\/doi.org\/10.1038\/nature09783","journal-title":"Nature"},{"issue":"30","key":"12573_CR20","doi-asserted-by":"publisher","first-page":"11151","DOI":"10.1073\/pnas.1401724111","volume":"111","author":"KM Akat","year":"2014","unstructured":"Akat KM, Moore-McGriff D, Morozov P, Brown M, Gogakos T, Correa Da Rosa J, Mihailovic A, Sauer M, Ji R, Ramarathnam A, Totary-Jain H, Williams Z, Tuschl T, Schulze PC (2014) Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers. Proc Natl Acad Sci USA 111(30):11151\u201311156. https:\/\/doi.org\/10.1073\/pnas.1401724111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"12573_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15(8):509\u2013524. https:\/\/doi.org\/10.1038\/nrm3838","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"12573_CR22","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1073\/pnas.0710228105","volume":"105","author":"JF Chen","year":"2008","unstructured":"Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G, Patterson C, Hannon GJ, Wang DZ (2008) Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA 105(6):2111\u20132116. https:\/\/doi.org\/10.1073\/pnas.0710228105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"12573_CR23","doi-asserted-by":"publisher","first-page":"e0145930","DOI":"10.1371\/journal.pone.0145930","volume":"10","author":"C Schulte","year":"2015","unstructured":"Schulte C, Molz S, Appelbaum S, Karakas M, Ojeda F, Lau DM, Hartmann T, Lackner KJ, Westermann D, Schnabel RB, Blankenberg S, Zeller T (2015) MiRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease. PLoS ONE 10(12):e0145930. https:\/\/doi.org\/10.1371\/journal.pone.0145930","journal-title":"PLoS ONE"},{"key":"12573_CR24","doi-asserted-by":"publisher","first-page":"668324","DOI":"10.3389\/fgene.2021.668324","volume":"12","author":"B Wang","year":"2021","unstructured":"Wang B, Li Y, Hao X, Yang J, Han X, Li H, Li T, Wang D, Teng Y, Ma L, Li Y, Zhao M, Wang X (2021) Comparison of the Clinical Value of miRNAs and Conventional Biomarkers in AMI: A Systematic Review. Front Genet 12:668324. https:\/\/doi.org\/10.3389\/fgene.2021.668324","journal-title":"Front Genet"},{"key":"12573_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yjmcc.2013.09.012","volume":"65","author":"DW Kuster","year":"2013","unstructured":"Kuster DW, Mulders J, Ten Cate FJ, Michels M, Dos Remedios CG, da Costa Martins PA, van der Velden J, Oudejans CB (2013) MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations. J Mol Cell Cardiol 65:59\u201366. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.09.012","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"12573_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/CIRCRESAHA.109.200451","volume":"105","author":"PK Rao","year":"2009","unstructured":"Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, Reinhardt F, Liao R, Krieger M, Jaenisch R, Lodish HF, Blelloch R (2009) Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circul Res 105(6):585\u2013594. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.200451","journal-title":"Circul Res"},{"issue":"5","key":"12573_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ejhf.495","volume":"18","author":"EL Vegter","year":"2016","unstructured":"Vegter EL, van der Meer P, de Windt LJ, Pinto YM, Voors AA (2016) MicroRNAs in heart failure: from biomarker to target for therapy. Eur J Heart Fail 18(5):457\u2013468. https:\/\/doi.org\/10.1002\/ejhf.495","journal-title":"Eur J Heart Fail"},{"issue":"30","key":"12573_CR28","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O\u2019Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513\u201310518. https:\/\/doi.org\/10.1073\/pnas.0804549105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"12573_CR29","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","volume":"56","author":"JA Weber","year":"2010","unstructured":"Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56(11):1733\u20131741. https:\/\/doi.org\/10.1373\/clinchem.2010.147405","journal-title":"Clin Chem"},{"key":"12573_CR30","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3389\/fphar.2019.01500","volume":"10","author":"NM Kamal","year":"2020","unstructured":"Kamal NM, N. N. S. B., Shahidan WNS (2020) Non-exosomal and exosomal circulatory microRNAs: Which are more valid as biomarkers? Front Pharmacol 10:1500. https:\/\/doi.org\/10.3389\/fphar.2019.01500","journal-title":"Front Pharmacol"},{"issue":"3","key":"12573_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1152\/physiolgenomics.00211.2009","volume":"42","author":"C Voellenkle","year":"2010","unstructured":"Voellenkle C, van Rooij J, Cappuzzello C, Greco S, Arcelli D, Di Vito L, Melillo G, Rigolini R, Costa E, Crea F, Capogrossi MC, Napolitano M, Martelli F (2010) MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genom 42(3):420\u2013426. https:\/\/doi.org\/10.1152\/physiolgenomics.00211.2009","journal-title":"Physiol Genom"},{"issue":"4","key":"12573_CR32","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1111\/jcmm.13535","volume":"22","author":"P Rubi\u015b","year":"2018","unstructured":"Rubi\u015b P, Toto\u0144-\u017bura\u0144ska J, Wi\u015bniowska-\u015amia\u0142ek S, Dziewi\u0119cka E, Ko\u0142ton-Wr\u00f3\u017c M, Wo\u0142kow P, Pitera E, Rudnicka-Sosin L, Garlitski AC, Gackowski A, Podolec P (2018) The relationship between myocardial fibrosis and myocardial microRNAs in dilated cardiomyopathy: A link between mir-133a and cardiovascular events. J Cell Mol Med 22(4):2514\u20132517. https:\/\/doi.org\/10.1111\/jcmm.13535","journal-title":"J Cell Mol Med"},{"key":"12573_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijcard.2016.11.279","volume":"231","author":"P Rubi\u015b","year":"2017","unstructured":"Rubi\u015b P, Toto\u0144-\u017bura\u0144ska J, Wi\u015bniowska-\u015amia\u0142ek S, Holcman K, Ko\u0142ton-Wr\u00f3\u017c M, Wo\u0142kow P, Wypasek E, Natorska J, Rudnicka-Sosin L, Pawlak A, Kozanecki A, Podolec P (2017) Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy. Int J Cardiol 231:201\u2013206. https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.279","journal-title":"Int J Cardiol"},{"issue":"6","key":"12573_CR34","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1002\/ehf2.14523","volume":"10","author":"G Aleshcheva","year":"2023","unstructured":"Aleshcheva G, Baumeier C, Harms D, Bock CT, Escher F, Schultheiss HP (2023) MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy. ESC heart Fail 10(6):3410\u20133418. https:\/\/doi.org\/10.1002\/ehf2.14523","journal-title":"ESC heart Fail"},{"issue":"35","key":"12573_CR35","doi-asserted-by":"publisher","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E van Rooij","year":"2008","unstructured":"van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105(35):13027\u201313032. https:\/\/doi.org\/10.1073\/pnas.0805038105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7224","key":"12573_CR36","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Engelhardt S (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456(7224):980\u2013984. https:\/\/doi.org\/10.1038\/nature07511","journal-title":"Nature"},{"issue":"1","key":"12573_CR37","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41467-017-00972-z","volume":"8","author":"M Mann","year":"2017","unstructured":"Mann M, Mehta A, Zhao JL, Lee K, Marinov GK, Garcia-Flores Y, Lu LF, Rudensky AY, Baltimore D (2017) An NF-\u03baB-microRNA regulatory network tunes macrophage inflammatory responses. Nat Commun 8(1):851. https:\/\/doi.org\/10.1038\/s41467-017-00972-z","journal-title":"Nat Commun"},{"key":"12573_CR38","doi-asserted-by":"publisher","first-page":"30034","DOI":"10.1038\/s41598-024-78983-2","volume":"14","author":"J Yan","year":"2024","unstructured":"Yan J, Wang X, Cao P, Li Q, Wu H (2024) Downregulation of miR-214 promotes dilated cardiomyopathy progression through PDE5A-mediated cGMP regulation. Sci Rep 14:30034. https:\/\/doi.org\/10.1038\/s41598-024-78983-2","journal-title":"Sci Rep"},{"issue":"5","key":"12573_CR39","doi-asserted-by":"publisher","first-page":"e1258","DOI":"10.1002\/ctm2.1258","volume":"13","author":"X Cheng","year":"2023","unstructured":"Cheng X, Jian D, Xing J, Liu C, Liu Y, Cui C, Li Z, Wang S, Li R, Ma X, Wang Y, Gu X, Ge Z, Tang H, Liu L (2023) Circulating cardiac microRNAs safeguard against dilated cardiomyopathy. Clin Translational Med 13(5):e1258. https:\/\/doi.org\/10.1002\/ctm2.1258","journal-title":"Clin Translational Med"},{"issue":"14","key":"12573_CR40","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/jcmm.17789","volume":"27","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhang G, Lu Y, Gao J, Qin Z, Xu S, Wang Z, Xu Y, Yang Y, Zhang J, Tang J (2023) Differential expression profiles of plasma exosomal microRNAs in dilated cardiomyopathy with chronic heart failure. J Cell Mol Med 27(14):1988\u20132003. https:\/\/doi.org\/10.1111\/jcmm.17789","journal-title":"J Cell Mol Med"},{"issue":"6","key":"12573_CR41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.healun.2017.02.008","volume":"36","author":"D Scrutinio","year":"2017","unstructured":"Scrutinio D, Conserva F, Passantino A, Iacoviello M, Lagioia R, Gesualdo L (2017) Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study. J heart lung transplantation: official publication Int Soc Heart Transplantation 36(6):616\u2013624. https:\/\/doi.org\/10.1016\/j.healun.2017.02.008","journal-title":"J heart lung transplantation: official publication Int Soc Heart Transplantation"},{"key":"12573_CR42","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.1038\/s41598-021-87086-1","volume":"11","author":"M Calderon-Dominguez","year":"2021","unstructured":"Calderon-Dominguez M, Belmonte T, Quezada-Feijoo M, Ramos M, Calderon-Dominguez J, Campuzano O, Mangas A, Toro R (2021) Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy. Sci Rep 11:7517. https:\/\/doi.org\/10.1038\/s41598-021-87086-1","journal-title":"Sci Rep"},{"key":"12573_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.01.003","volume":"218","author":"T Belmonte","year":"2020","unstructured":"Belmonte T, Mangas A, Calder\u00f3n-Dom\u00ednguez M, Quezada-Feijoo M, Ramos M, Campuzano O, G\u00f3mez S, Pe\u00f1a ML, Cubillos-Arango AM, Dom\u00ednguez F, Llorente-Cort\u00e9s V, de Gonzalo-Calvo D, Toro R (2020) Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy. Translational Res 218:1\u201315. https:\/\/doi.org\/10.1016\/j.trsl.2020.01.003","journal-title":"Translational Res"},{"key":"12573_CR44","doi-asserted-by":"publisher","unstructured":"Zaragoza C, Saura M, Hern\u00e1ndez I, Ram\u00edrez-Carracedo R, Garc\u00eda-Garc\u00eda F, Zamorano JL, Mangas A, Toro R (2019) Differential expression of circulating miRNAs as a novel tool to assess BAG3-associated familial dilated cardiomyopathy. Biosci Rep 39(3) Article BSR20180934. https:\/\/doi.org\/10.1042\/BSR20180934","DOI":"10.1042\/BSR20180934"},{"issue":"5","key":"12573_CR45","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1159\/000489383","volume":"46","author":"T Wu","year":"2018","unstructured":"Wu T, Chen Y, Du Y, Tao J, Zhou Z, Yang Z (2018) Serum Exosomal MiR-92b-5p as a Potential Biomarker for Acute Heart Failure Caused by Dilated Cardiomyopathy. Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol 46(5):1939\u20131950. https:\/\/doi.org\/10.1159\/000489383","journal-title":"Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol"},{"issue":"11","key":"12573_CR46","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1089\/gtmb.2018.0188","volume":"22","author":"ST Onrat","year":"2018","unstructured":"Onrat ST, Onrat E, Ercan Onay E, Yal\u0131m Z, Av\u015far A (2018) The Genetic Determination of the Differentiation Between Ischemic Dilated Cardiomyopathy and Idiopathic Dilated Cardiomyopathy. Genetic Test Mol biomarkers 22(11):644\u2013651. https:\/\/doi.org\/10.1089\/gtmb.2018.0188","journal-title":"Genetic Test Mol biomarkers"},{"issue":"1","key":"12573_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5603\/CJ.a2016.0097","volume":"24","author":"H Wang","year":"2017","unstructured":"Wang H, Chen F, Tong J, Li Y, Cai J, Wang Y, Li P, Hao Y, Tian W, Lv Y, Chong J, Yang J (2017) Circulating microRNAs as novel biomarkers for dilated cardiomyopathy. Cardiol J 24(1):65\u201373. https:\/\/doi.org\/10.5603\/CJ.a2016.0097","journal-title":"Cardiol J"},{"key":"12573_CR48","doi-asserted-by":"publisher","first-page":"33580","DOI":"10.1038\/srep33580","volume":"6","author":"M Yu","year":"2016","unstructured":"Yu M, Liang W, Xie Y, Long Q, Cheng X, Liao Y, Yuan J (2016) Circulating miR-185 might be a novel biomarker for clinical outcome in patients with dilated cardiomyopathy. Sci Rep 6:33580. https:\/\/doi.org\/10.1038\/srep33580","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"12573_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11010-012-1546-x","volume":"376","author":"N Nair","year":"2013","unstructured":"Nair N, Kumar S, Gongora E, Gupta S (2013) Circulating miRNA as novel markers for diastolic dysfunction. Mol Cell Biochem 376(1\u20132):33\u201340. https:\/\/doi.org\/10.1007\/s11010-012-1546-x","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"12573_CR50","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1161\/CIRCRESAHA.110.218297","volume":"106","author":"AJ Tijsen","year":"2010","unstructured":"Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM (2010) MiR423-5p as a circulating biomarker for heart failure. Circul Res 106(6):1035\u20131039. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.218297","journal-title":"Circul Res"},{"issue":"1","key":"12573_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/1354750X.2015.1118533","volume":"21","author":"M Enes Co\u015fkun","year":"2016","unstructured":"Enes Co\u015fkun M, Kervanc\u0131o\u011flu M, \u00d6ztuzcu S, Y\u0131lmaz Co\u015fkun F, Erg\u00fcn S, Ba\u015fp\u0131nar O, K\u0131l\u0131n\u00e7 M, Temel L, Co\u015fkun MY (2016) Plasma microRNA profiling of children with idiopathic dilated cardiomyopathy. Biomarkers: Biochem Indic exposure response susceptibility chemicals 21(1):56\u201361. https:\/\/doi.org\/10.3109\/1354750X.2015.1118533","journal-title":"Biomarkers: Biochem Indic exposure response susceptibility chemicals"},{"issue":"9","key":"12573_CR52","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3390\/jcdd10090391","volume":"10","author":"FT Hailu","year":"2023","unstructured":"Hailu FT, Karimpour-Fard A, Neltner B, Stauffer BL, Lipshultz S, Miyamoto SD, Sucharov CC (2023) Circulating and Cardiac Tissue miRNAs in Children with Dilated Cardiomyopathy. J Cardiovasc Dev Disease 10(9):391. https:\/\/doi.org\/10.3390\/jcdd10090391","journal-title":"J Cardiovasc Dev Disease"},{"issue":"5","key":"12573_CR53","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.healun.2015.01.979","volume":"34","author":"SD Miyamoto","year":"2015","unstructured":"Miyamoto SD, Karimpour-Fard A, Peterson V, Auerbach SR, Stenmark KR, Stauffer BL, Sucharov CC (2015) Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy. J Heart Lung Transplantation 34(5):724\u2013733. https:\/\/doi.org\/10.1016\/j.healun.2015.01.979","journal-title":"J Heart Lung Transplantation"},{"issue":"1","key":"12573_CR54","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41598-017-19138-4","volume":"8","author":"M Jiao","year":"2018","unstructured":"Jiao M, You HZ, Yang XY, Yuan H, Li YL, Liu WX, Jin M, Du J (2018) Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy. Sci Rep 8(1):724. https:\/\/doi.org\/10.1038\/s41598-017-19138-4","journal-title":"Sci Rep"},{"issue":"5","key":"12573_CR55","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/JCI70577","volume":"124","author":"C Bang","year":"2014","unstructured":"Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, Ponimaskin E, Schmiedl A, Yin X, Mayr M, Halder R, Fischer A, Engelhardt S, Wei Y, Schober A, Thum T (2014) Cardiac fibroblast\u2013derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Investig 124(5):2136. https:\/\/doi.org\/10.1172\/JCI70577","journal-title":"J Clin Investig"},{"issue":"5","key":"12573_CR56","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.3390\/molecules19056080","volume":"19","author":"JR Chevillet","year":"2014","unstructured":"Chevillet JR, Lee I, Briggs HA, He Y, Wang K (2014) Issues and Prospects of microRNA-Based Biomarkers in Blood and Other Body Fluids. Molecules 19(5):6080. https:\/\/doi.org\/10.3390\/molecules19056080","journal-title":"Molecules"},{"issue":"3","key":"12573_CR57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/biom14030309","volume":"14","author":"R Licordari","year":"2024","unstructured":"Licordari R, Correale M, Bonanno S, Beltrami M, Ciccarelli M, Micari A, Palazzuoli A, Dattilo G (2024) Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure. Biomolecules 14(3):309. https:\/\/doi.org\/10.3390\/biom14030309","journal-title":"Biomolecules"},{"issue":"2","key":"12573_CR58","doi-asserted-by":"publisher","first-page":"480","DOI":"10.5114\/aoms.2019.89777","volume":"18","author":"P Rubi\u015b","year":"2022","unstructured":"Rubi\u015b P, Toto\u0144-\u017bura\u0144ska J, Ko\u0142ton-Wr\u00f3\u017c M et al (2022) Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy. Archives Med Sci 18(2):480\u2013488. https:\/\/doi.org\/10.5114\/aoms.2019.89777","journal-title":"Archives Med Sci"},{"key":"12573_CR59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.trsl.2019.08.007","volume":"215","author":"M Calderon-Dominguez","year":"2019","unstructured":"Calderon-Dominguez M, Belmonte T, Quezada-Feijoo M, Ramos-S\u00e1nchez M, Fern\u00e1ndez-Armenta J, P\u00e9rez-Navarro A, Cesar S, Pe\u00f1a-Pe\u00f1a L, Vea \u00c0, Llorente-Cort\u00e9s V, Mangas A, De Gonzalo-Calvo D, Toro R (2019) Emerging role of microRNAs in dilated cardiomyopathy: Evidence regarding etiology. Translational Res 215:86\u2013101. https:\/\/doi.org\/10.1016\/j.trsl.2019.08.007","journal-title":"Translational Res"},{"issue":"9","key":"12573_CR60","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1373\/clinchem.2017.285288","volume":"64","author":"MWJ de Ronde","year":"2018","unstructured":"de Ronde MWJ, Ruijter JM, Moerland PD, Creemers EE, Pinto-Sietsma SJ (2018) Study Design and qPCR Data Analysis Guidelines for Reliable Circulating miRNA Biomarker Experiments: A Review. Clin Chem 64(9):1308\u20131318. https:\/\/doi.org\/10.1373\/clinchem.2017.285288","journal-title":"Clin Chem"},{"issue":"1","key":"12573_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/00045632221129778","volume":"60","author":"C Mestry","year":"2023","unstructured":"Mestry C, Ashavaid TF, Shah SA (2023) Key methodological challenges in detecting circulating miRNAs in different biofluids. Ann Clin Biochem 60(1):14\u201326. https:\/\/doi.org\/10.1177\/00045632221129778","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"12573_CR62","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1038\/emm.2017.288","volume":"50","author":"D Poel","year":"2018","unstructured":"Poel D, Buffart TE, Oosterling-Jansen J, Verheul HM, Voortman J (2018) Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer. Exp Mol Med 50(3):e454. https:\/\/doi.org\/10.1038\/emm.2017.288","journal-title":"Exp Mol Med"},{"issue":"2","key":"12573_CR63","doi-asserted-by":"publisher","first-page":"e23765","DOI":"10.1016\/j.heliyon.2023.e23765","volume":"10","author":"AS Rizzuto","year":"2024","unstructured":"Rizzuto AS, Faggiano A, Macchi C, Carugo S, Perrino C, Ruscica M (2024) Extracellular vesicles in cardiomyopathies: A narrative review. Heliyon 10(2):e23765. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23765","journal-title":"Heliyon"},{"issue":"4","key":"12573_CR64","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1002\/ctm2.779","volume":"12","author":"P Sun","year":"2022","unstructured":"Sun P, Wang C, Mang G, Xu X, Fu S, Chen J, Wang X, Wang W, Li H, Zhao P, Li Y, Chen Q, Wang N, Tong Z, Fu X, Lang Y, Duan S, Liu D, Zhang M, Tian J (2022) Extracellular vesicle-packaged mitochondrial disturbing miRNA exacerbates cardiac injury during acute myocardial infarction. Clin translational Med 12(4):e779. https:\/\/doi.org\/10.1002\/ctm2.779","journal-title":"Clin translational Med"},{"issue":"8","key":"12573_CR65","doi-asserted-by":"publisher","first-page":"e0136665","DOI":"10.1371\/journal.pone.0136665","volume":"10","author":"ML Bertoia","year":"2015","unstructured":"Bertoia ML, Bertrand KA, Sawyer SJ, Rimm EB, Mukamal KJ (2015) Reproducibility of Circulating MicroRNAs in Stored Plasma Samples. PLoS ONE 10(8):e0136665. https:\/\/doi.org\/10.1371\/journal.pone.0136665","journal-title":"PLoS ONE"},{"issue":"2","key":"12573_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/aje\/kwu135","volume":"180","author":"VS Nair","year":"2014","unstructured":"Nair VS, Pritchard CC, Tewari M, Ioannidis JP (2014) Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies. Am J Epidemiol 180(2):140\u2013152. https:\/\/doi.org\/10.1093\/aje\/kwu135","journal-title":"Am J Epidemiol"},{"issue":"2","key":"12573_CR67","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ehf2.14153","volume":"10","author":"P Gargiulo","year":"2023","unstructured":"Gargiulo P, Marzano F, Salvatore M, Basile C, Buonocore D, Parlati AL, Nardi E, Asile G, Abbate V, Colella A, Chirico A, Marciano C, Paolillo S, Perrone-Filardi P (2023) MicroRNAs: Diagnostic, Prognostic and Therapeutic Role in Heart Failure\u2014A Review. ESC Heart Fail 10(2):753\u2013761. https:\/\/doi.org\/10.1002\/ehf2.14153","journal-title":"ESC Heart Fail"},{"key":"12573_CR68","doi-asserted-by":"publisher","first-page":"120304","DOI":"10.1016\/j.cca.2025.120304","volume":"574","author":"F He","year":"2025","unstructured":"He F, Guan W (2025) The role of miR-21 as a biomarker and therapeutic target in cardiovascular disease. Clin Chim Acta 574:120304. https:\/\/doi.org\/10.1016\/j.cca.2025.120304","journal-title":"Clin Chim Acta"},{"key":"12573_CR69","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","volume":"107","author":"O Adam","year":"2012","unstructured":"Adam O, L\u00f6hfelm B, Thum T et al (2012) Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res Cardiol 107:278. https:\/\/doi.org\/10.1007\/s00395-012-0278-0","journal-title":"Basic Res Cardiol"},{"key":"12573_CR70","doi-asserted-by":"publisher","unstructured":"Zhao X, Wang P (2025) Interpretation of the molecular mechanism and therapeutic potential of microRNA-155 in cardiovascular and cerebrovascular diseases (Review). Int J Mol Med 57(1). https:\/\/doi.org\/10.3892\/ijmm.2025.5681","DOI":"10.3892\/ijmm.2025.5681"},{"issue":"20","key":"12573_CR71","doi-asserted-by":"publisher","first-page":"10933","DOI":"10.3390\/ijms252010933","volume":"25","author":"E M\u0142ynarska","year":"2024","unstructured":"M\u0142ynarska E, Badura K, Kurci\u0144ski S, Sinkowska J, Jakubowska P, Rysz J, Franczyk B (2024) The Role of MicroRNA in the Pathophysiology and Diagnosis of Viral Myocarditis. Int J Mol Sci 25(20):10933. https:\/\/doi.org\/10.3390\/ijms252010933","journal-title":"Int J Mol Sci"},{"issue":"5","key":"12573_CR72","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","volume":"107","author":"S Fichtlscherer","year":"2010","unstructured":"Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, R\u00f6xe T, M\u00fcller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S (2010) Circulating microRNAs in patients with coronary artery disease. Circul Res 107(5):677\u2013684. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.215566","journal-title":"Circul Res"},{"issue":"2","key":"12573_CR73","doi-asserted-by":"publisher","first-page":"e57800","DOI":"10.1371\/journal.pone.0057800","volume":"8","author":"S Leptidis","year":"2013","unstructured":"Leptidis S, Lok SI, Olieslagers S, Kisters N, Silva GJ, Heymans S, Cuppen E, Berezikov E, De Windt LJ, Martins C (2013) A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart. PLoS ONE 8(2):e57800. https:\/\/doi.org\/10.1371\/journal.pone.0057800","journal-title":"PLoS ONE"},{"issue":"5","key":"12573_CR74","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biom14050524","volume":"14","author":"F Bonet","year":"2024","unstructured":"Bonet F, Hernandez-Torres F, Ramos-S\u00e1nchez M, Quezada-Feijoo M, Berm\u00fadez-Garc\u00eda A, Daroca T, Alonso-Villa E, Garc\u00eda-Padilla C, Mangas A, Toro R (2024) Unraveling the Etiology of Dilated Cardiomyopathy through Differential miRNA\u2013mRNA Interactome. Biomolecules 14(5):524. https:\/\/doi.org\/10.3390\/biom14050524","journal-title":"Biomolecules"},{"issue":"6","key":"12573_CR75","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/eurjhf\/hft018","volume":"15","author":"BA Dickinson","year":"2013","unstructured":"Dickinson BA, Semus HM, Montgomery RL, Stack C, Latimer PA, Lewton SM, Lynch JM, Hullinger TG, Seto AG, Van Rooij E (2013) Plasma microRNAs Serve as Biomarkers of Therapeutic Efficacy and Disease Progression in Hypertension-Induced Heart Failure. Eur J Heart Fail 15(6):650\u2013659. https:\/\/doi.org\/10.1093\/eurjhf\/hft018","journal-title":"Eur J Heart Fail"},{"key":"12573_CR76","doi-asserted-by":"publisher","first-page":"e1818","DOI":"10.31661\/gmj.v9i0.1818","volume":"9","author":"SR Sadat-Ebrahimi","year":"2020","unstructured":"Sadat-Ebrahimi SR, Aslanabadi N (2020) Role of MicroRNAs in Diagnosis, Prognosis, and Treatment of Acute Heart Failure: Ambassadors from Intracellular Zone. Galen Med J 9:e1818. https:\/\/doi.org\/10.31661\/gmj.v9i0.1818","journal-title":"Galen Med J"},{"issue":"9","key":"12573_CR77","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.rec.2017.05.013","volume":"70","author":"D de Gonzalo-Calvo","year":"2017","unstructured":"de Gonzalo-Calvo D, Iglesias-Guti\u00e9rrez E, Llorente-Cort\u00e9s V (2017) Epigenetic biomarkers and cardiovascular disease: Circulating microRNAs. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 70(9):763\u2013769. https:\/\/doi.org\/10.1016\/j.rec.2017.05.013","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"9","key":"12573_CR78","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/CIRCRESAHA.108.183426","volume":"103","author":"WS Marshall","year":"2008","unstructured":"Marshall WS, Olson EN (2008) Toward MicroRNA-Based Therapeutics for Heart Disease - the sense in antisense. Circul Res 103(9):919. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.183426","journal-title":"Circul Res"},{"issue":"21","key":"12573_CR79","doi-asserted-by":"publisher","first-page":"13573","DOI":"10.3390\/ijms232113573","volume":"23","author":"E Alonso-Villa","year":"2022","unstructured":"Alonso-Villa E, Bonet F, Hernandez-Torres F, Campuzano \u00d3, Sarquella-Brugada G, Quezada-Feijoo M, Ramos M, Mangas A, Toro R (2022) The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity. Int J Mol Sci 23(21):13573. https:\/\/doi.org\/10.3390\/ijms232113573","journal-title":"Int J Mol Sci"},{"key":"12573_CR80","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12935-020-01335-x","volume":"20","author":"B Otoukesh","year":"2020","unstructured":"Otoukesh B, Abbasi M, Gorgani HF, Farahini H, Moghtadaei M, Boddouhi B, Kaghazian P, Hosseinzadeh S, Alaee A (2020) MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma. Cancer Cell Int 20:254. https:\/\/doi.org\/10.1186\/s12935-020-01335-x","journal-title":"Cancer Cell Int"},{"issue":"2","key":"12573_CR81","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","volume":"42","author":"J T\u00e4ubel","year":"2021","unstructured":"T\u00e4ubel J, Hauke W, Rump S, Viereck J, Batkai S, Poetzsch J, Rode L, Weigt H, Genschel C, Lorch U, Theek C, Levin AA, Bauersachs J, Solomon SD, Thum T (2021) Novel antisense therapy targeting microRNA-132 in patients with heart failure: Results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. Eur Heart J 42(2):178\u2013188. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa898","journal-title":"Eur Heart J"},{"issue":"1","key":"12573_CR82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/emmm.201100191","volume":"4","author":"T Thum","year":"2012","unstructured":"Thum T (2012) MicroRNA therapeutics in cardiovascular medicine. EMBO Mol Med 4(1):3\u201314. https:\/\/doi.org\/10.1002\/emmm.201100191","journal-title":"EMBO Mol Med"},{"key":"12573_CR83","doi-asserted-by":"publisher","unstructured":"Raso A, Dirkx E, Philippen LE, Fernandez-Celis A, De Majo F, Sampaio-Pinto V, Sansonetti M, Juni R, El Azzouzi H, Calore M, Bitsch N (2019). Therapeutic Delivery of miR-148a Suppresses Ventricular Dilation in Heart Failure. Molecular therapy: the journal of the American Society of Gene Therapy, 27(3), 584\u2013599. https:\/\/doi.org\/10.1016\/j.ymthe.2018.11.011","DOI":"10.1016\/j.ymthe.2018.11.011"},{"issue":"5","key":"12573_CR84","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","volume":"2","author":"AGE Ibrahim","year":"2014","unstructured":"Ibrahim AGE, Cheng K, Marb\u00e1n E (2014) Exosomes as Critical Agents of Cardiac Regeneration Triggered by Cell Therapy. Stem Cell Rep 2(5):606. https:\/\/doi.org\/10.1016\/j.stemcr.2014.04.006","journal-title":"Stem Cell Rep"},{"key":"12573_CR85","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s44395-026-00048-2","volume":"2","author":"R Wasim","year":"2026","unstructured":"Wasim R, Singh A (2026) Engineered exosome nanocarriers for targeted cardiovascular therapy. Discov Pharm Sci 2:14. https:\/\/doi.org\/10.1007\/s44395-026-00048-2","journal-title":"Discov Pharm Sci"},{"issue":"15","key":"12573_CR86","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.jacc.2020.03.003","volume":"75","author":"J-S Hulot","year":"2020","unstructured":"Hulot J-S, Masurkar N (2020) miRNA-based therapeutics for heart failure: Why not? J Am Coll Cardiol 75(15):1801\u20131803. https:\/\/doi.org\/10.1016\/j.jacc.2020.03.003","journal-title":"J Am Coll Cardiol"},{"key":"12573_CR87","doi-asserted-by":"publisher","first-page":"27","DOI":"10.20517\/2574-1209.2023.69","volume":"7","author":"S Maiocchi","year":"2023","unstructured":"Maiocchi S, Collins EN, Peterson AR, Alexander KC, McGlamery DJ, Cassidy NA, Ikonomidis JS, Akerman AW (2023) Plasma microrna quantification protocol. Vessel plus 7:27. https:\/\/doi.org\/10.20517\/2574-1209.2023.69","journal-title":"Vessel plus"},{"key":"12573_CR88","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2022.12.003","volume":"374","author":"G Saenz-Pipaon","year":"2023","unstructured":"Saenz-Pipaon G, Dichek DA (2023) Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases. Atherosclerosis 374:44\u201354. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.12.003","journal-title":"Atherosclerosis"},{"issue":"6","key":"12573_CR89","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1093\/nar\/gkae141","volume":"52","author":"M Garreau","year":"2024","unstructured":"Garreau M, Weidner J, Hamilton R, Kolosionek E, Toki N, Stavenhagen K, Paris C, Bonetti A, Czechtizky W, Gnerlich F, Rydzik A (2024) Chemical modification patterns for microRNA therapeutic mimics: A structure-activity relationship (SAR) case-study on miR-200c. Nucleic Acids Res 52(6):2792. https:\/\/doi.org\/10.1093\/nar\/gkae141","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"12573_CR90","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00018-017-2656-0","volume":"75","author":"H Seok","year":"2018","unstructured":"Seok H, Lee H, Jang ES, Chi SW (2018) Evaluation and control of miRNA-like off-target repression for RNA interference. Cell Mol Life Sci 75(5):797\u2013814. https:\/\/doi.org\/10.1007\/s00018-017-2656-0","journal-title":"Cell Mol Life Sci"},{"key":"12573_CR91","doi-asserted-by":"publisher","first-page":"175394472412531","DOI":"10.1177\/17539447241253134","volume":"18","author":"A Khalaji","year":"2024","unstructured":"Khalaji A, Mehrtabar S, Jabraeilipour A, Doustar N, Youshanlouei R, Tahavvori H, Fattahi A, Alavi P, Taha SMA, Fazlollahpour-Naghibi SR, A., Zadeh S, M (2024) Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development. Ther Adv Cardiovasc Dis 18:17539447241253134. https:\/\/doi.org\/10.1177\/17539447241253134","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"5","key":"12573_CR92","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3390\/ijms27052162","volume":"27","author":"H V\u00e9lez-Slimani","year":"2026","unstructured":"V\u00e9lez-Slimani H, Salazar LA (2026) Therapeutic microRNAs: Mechanisms, Delivery, and Clinical Translation in Oncology. Int J Mol Sci 27(5):2162. https:\/\/doi.org\/10.3390\/ijms27052162","journal-title":"Int J Mol Sci"},{"issue":"6","key":"12573_CR93","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s12265-025-10629-8","volume":"18","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yuan Y, Tang J (2025) Extracellular Vesicles as Diagnostic Metrics for Cardiovascular Disease: Where We are and How to Achieve in Clinics. J Cardiovasc Transl Res 18(6):1555\u20131565. https:\/\/doi.org\/10.1007\/s12265-025-10629-8","journal-title":"J Cardiovasc Transl Res"},{"issue":"8","key":"12573_CR94","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","volume":"20","author":"M Winkle","year":"2021","unstructured":"Winkle M, El-Daly SM, Fabbri M, Calin GA (2021) Noncoding RNA therapeutics \u2014 Challenges and potential solutions. Nat Rev Drug Discov 20(8):629. https:\/\/doi.org\/10.1038\/s41573-021-00219-z","journal-title":"Nat Rev Drug Discov"},{"key":"12573_CR95","doi-asserted-by":"publisher","first-page":"787614","DOI":"10.3389\/fcvm.2021.787614","volume":"8","author":"C Asher","year":"2021","unstructured":"Asher C, Puyol-Ant\u00f3n E, Rizvi M, Ruijsink B, Chiribiri A, Razavi R, Carr-White G (2021) The role of AI in characterizing the DCM phenotype. Front Cardiovasc Med 8:787614. https:\/\/doi.org\/10.3389\/fcvm.2021.787614","journal-title":"Front Cardiovasc Med"},{"key":"12573_CR96","doi-asserted-by":"publisher","first-page":"1735094","DOI":"10.3389\/fcvm.2026.1735094","volume":"13","author":"I Antoun","year":"2026","unstructured":"Antoun I, Alkhayer A, Abdelrazik A, Eldesouky M, Thu KM, Ibrahim M, Dhutia H, Somani R, Ng GA (2026) From polygenic risk to digital twins: The future of personalised cardiovascular medicine. Front Cardiovasc Med 13:1735094. https:\/\/doi.org\/10.3389\/fcvm.2026.1735094","journal-title":"Front Cardiovasc Med"},{"key":"12573_CR97","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12933-023-01957-7","volume":"22","author":"M Samadishadlou","year":"2023","unstructured":"Samadishadlou M, Rahbarghazi R, Piryaei Z, Esmaeili M, Avc\u0131 \u00c7B, Bani F, Kavousi K (2023) Unlocking the potential of microRNAs: Machine learning identifies key biomarkers for myocardial infarction diagnosis. Cardiovasc Diabetol 22:247. https:\/\/doi.org\/10.1186\/s12933-023-01957-7","journal-title":"Cardiovasc Diabetol"},{"key":"12573_CR98","doi-asserted-by":"publisher","first-page":"106321","DOI":"10.1016\/j.ijmedinf.2026.106321","volume":"211","author":"M Jaradat","year":"2026","unstructured":"Jaradat M, Awad M (2026) Explainable AI in Cardiology Diagnostics: A Systematic Review of Machine Learning, Meta-heuristic Optimization, and Clinical Text Mining for Coronary Artery Disease. Int J Med Informatics 211:106321. https:\/\/doi.org\/10.1016\/j.ijmedinf.2026.106321","journal-title":"Int J Med Informatics"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12573-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12573-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12573-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:11:48Z","timestamp":1786702308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12573-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12573"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12573-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"1407"}}